Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Line Guénette

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Pharmacoepidemiology and Drug Safety|December 5, 2019
Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter?Adjo Enyonam Akator, Claudia Blais, Philippe Gamache, et al.
The Canadian Journal of Cardiology|November 5, 2013
Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiationLine Guénette, Marie-Claude Breton, Haithem Hamdi, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 30, 2017
Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United StatesRoojin Habibi, Line Guénette, Joel Lexchin, et al.
Drugs & Aging|May 11, 2019
Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?Jacinthe Leclerc, Claudia Blais, Louis Rochette, et al.
Circulation. Cardiovascular Quality and Outcomes|October 5, 2017
Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series AnalysisJacinthe Leclerc, Claudia Blais, Louis Rochette, et al.
CMAJ Open|May 10, 2017
Association between interpersonal continuity of care and medication adherence in type 2 diabetes: an observational cohort studyAnara Richi Dossa, Jocelyne Moisan, Line Guénette, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 25, 2018
Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series AnalysisJacinthe Leclerc, Claudia Blais, Louis Rochette, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|March 8, 2022
Experience and Appreciation of Health Care Teams Regarding a New Model of Pharmaceutical Care in Long-Term Care SettingsVéronique Turcotte, Edeltraut Kröger, Rachel Rouleau, et al.
Systematic Reviews|May 21, 2017
Polypharmacy in multimorbid older adults: protocol for a systematic reviewCaroline Sirois, Marie-Laure Laroche, Line Guénette, et al.
Patient Preference and Adherence|March 21, 2015
Patients' beliefs about adherence to oral antidiabetic treatment: a qualitative studyLine Guénette, Sophie Lauzier, Laurence Guillaumie, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Pharmacoepidemiology and Drug Safety|December 5, 2019
Exposure to guideline-recommended drugs after a first acute myocardial infarction in older adults: does deprivation matter?Adjo Enyonam Akator, Claudia Blais, Philippe Gamache, et al.
The Canadian Journal of Cardiology|November 5, 2013
Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiationLine Guénette, Marie-Claude Breton, Haithem Hamdi, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 30, 2017
Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United StatesRoojin Habibi, Line Guénette, Joel Lexchin, et al.
Drugs & Aging|May 11, 2019
Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?Jacinthe Leclerc, Claudia Blais, Louis Rochette, et al.
Circulation. Cardiovascular Quality and Outcomes|October 5, 2017
Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series AnalysisJacinthe Leclerc, Claudia Blais, Louis Rochette, et al.
CMAJ Open|May 10, 2017
Association between interpersonal continuity of care and medication adherence in type 2 diabetes: an observational cohort studyAnara Richi Dossa, Jocelyne Moisan, Line Guénette, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 25, 2018
Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series AnalysisJacinthe Leclerc, Claudia Blais, Louis Rochette, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|March 8, 2022
Experience and Appreciation of Health Care Teams Regarding a New Model of Pharmaceutical Care in Long-Term Care SettingsVéronique Turcotte, Edeltraut Kröger, Rachel Rouleau, et al.
Systematic Reviews|May 21, 2017
Polypharmacy in multimorbid older adults: protocol for a systematic reviewCaroline Sirois, Marie-Laure Laroche, Line Guénette, et al.
Patient Preference and Adherence|March 21, 2015
Patients' beliefs about adherence to oral antidiabetic treatment: a qualitative studyLine Guénette, Sophie Lauzier, Laurence Guillaumie, et al.
Pageof 11